Crescita Therapeutics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTX.TO research report →
Companywww.crescitatherapeutics.com
Crescita Therapeutics Inc. , a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services.
- CEO
- Serge Verreault
- IPO
- 2018
- Employees
- 71
- HQ
- Laval, QC, CA
Price Chart
Valuation
- Market Cap
- $14.15M
- P/E
- -44.21
- P/S
- 0.61
- P/B
- 0.98
- EV/EBITDA
- 5.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 52.39%
- Op Margin
- -5.02%
- Net Margin
- -1.38%
- ROE
- -2.07%
- ROIC
- -6.87%
Growth & Income
- Revenue
- $21.12M · 7.85%
- Net Income
- $-92,000 · 96.65%
- EPS
- $-0.00 · 96.50%
- Op Income
- $-1,022,000
- FCF YoY
- -51.95%
Performance & Tape
- 52W High
- $0.77
- 52W Low
- $0.40
- 50D MA
- $0.73
- 200D MA
- $0.53
- Beta
- -0.14
- Avg Volume
- 35.04K
Get TickerSpark's AI analysis on CTX.TO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CTX.TO Coverage
We haven't published any research on CTX.TO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CTX.TO Report →